| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.29 | 2e-08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 5e-08 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |